On October 10, 2019 Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, reported that management will participate in the following investor conferences during the months of October and November (Press release, Altimmune, OCT 10, 2019, View Source [SID1234540923]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 3rd Annual NASH Investor Conference
Date: Monday, October 21
Time: 11:20am ET
Speaker: M. Scott Harris M.D., Chief Medical Officer
Location: St. Regis Hotel, New York City
Webcast: View Source

BIO Investor Forum
Date: Wednesday, October 23
Time: 12:45pm ET/9:45am PT
Speaker: Vipin K. Garg Ph. D., President and Chief Executive Officer
Location: Westin St. Francis Hotel, San Francisco, CA
Webcast: View Source


Jefferies 2019 London Healthcare Conference
Date: November 20 and November 21 (one-on-one meetings only)
Attendees: Vipin K. Garg Ph.D., President and Chief Executive Officer
Will Brown, Chief Financial Officer
Location: Waldorf Hilton, London, UK